These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20406205)

  • 1. Pre-clinical safety evaluation of pyrrolidine dithiocarbamate.
    Chabicovsky M; Prieschl-Grassauer E; Seipelt J; Muster T; Szolar OH; Hebar A; Doblhoff-Dier O
    Basic Clin Pharmacol Toxicol; 2010 Sep; 107(3):758-67. PubMed ID: 20406205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary copper enhances the peripheral myelinopathy produced by oral pyrrolidine dithiocarbamate.
    Valentine HL; Amarnath K; Amarnath V; Valentine WM
    Toxicol Sci; 2006 Feb; 89(2):485-94. PubMed ID: 16291825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated exposure to pyrrolidine-dithiocarbamate induces peripheral nerve alterations in rats.
    Calviello G; Filippi GM; Toesca A; Palozza P; Maggiano N; Nicuolo FD; Serini S; Azzena GB; Galeotti T
    Toxicol Lett; 2005 Jul; 158(1):61-71. PubMed ID: 15993744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dithiocarbamate toxicity toward thymocytes involves their copper-catalyzed conversion to thiuram disulfides, which oxidize glutathione in a redox cycle without the release of reactive oxygen species.
    Burkitt MJ; Bishop HS; Milne L; Tsang SY; Provan GJ; Nobel CS; Orrenius S; Slater AF
    Arch Biochem Biophys; 1998 May; 353(1):73-84. PubMed ID: 9578602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protective effect of pyrrolidine dithiocarbamate in a rat model of liver cirrhosis.
    Bruck R; Schey R; Aeed H; Hochman A; Genina O; Pines M
    Liver Int; 2004 Apr; 24(2):169-76. PubMed ID: 15078482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal pyrrolidine dithiocarbamate decreases brain inflammatory mediators and provides neuroprotection after brain hypoxia-ischemia in neonatal rats.
    Wang Z; Zhao H; Peng S; Zuo Z
    Exp Neurol; 2013 Nov; 249():74-82. PubMed ID: 23994718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrrolidine dithiocarbamate prevents 60 minutes of warm mesenteric ischemia/reperfusion injury in rats.
    Teke Z; Kabay B; Aytekin FO; Yenisey C; Demirkan NC; Sacar M; Erdem E; Ozden A
    Am J Surg; 2007 Aug; 194(2):255-62. PubMed ID: 17618816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety pharmacology, toxicology and pharmacokinetic assessment of recombinant human omega-interferon produced from CHO-SS cells.
    Buckwold VE; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):62-70. PubMed ID: 16867173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicomponent T2 analysis of dithiocarbamate-mediated peripheral nerve demyelination.
    Valentine HL; Does MD; Marshall V; Tonkin EG; Valentine WM
    Neurotoxicology; 2007 May; 28(3):645-54. PubMed ID: 17350098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of NF-kappaB by pyrrolidine dithiocarbamate attenuates myocardial inflammatory response and ventricular dysfunction following coronary microembolization induced by homologous microthrombi in rats.
    Li S; Zhong S; Zeng K; Luo Y; Zhang F; Sun X; Chen L
    Basic Res Cardiol; 2010 Jan; 105(1):139-50. PubMed ID: 19823892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate.
    Kitamei H; Iwabuchi K; Namba K; Yoshida K; Yanagawa Y; Kitaichi N; Kitamura M; Ohno S; Onoé K
    J Leukoc Biol; 2006 Jun; 79(6):1193-201. PubMed ID: 16574770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in-vivo effect of pyrrolidine dithiocarbamate on hepatic parenchymal microcirculation and oxygenation of the rat liver.
    Seifalian AM; Mallick IH; Hajinasrollah E; Sogbodjor AL; Gustafsson BI; Delbro DS; Winslet MC
    Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1184-90. PubMed ID: 19474746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pyrrolidine dithiocarbamate on antioxidant enzymes in cardiomyopathy induced by adriamycin in rats.
    Mingyan E; Hongli L; Shufeng L; Bo Y
    Cardiology; 2008; 111(2):119-25. PubMed ID: 18376123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against kainate neurotoxicity by pyrrolidine dithiocarbamate.
    Shin EJ; Jhoo JH; Kim WK; Jhoo WK; Lee C; Jung BD; Kim HC
    Clin Exp Pharmacol Physiol; 2004; 31(5-6):320-6. PubMed ID: 15191405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
    Ress NB;
    Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.